Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Other Non Operating Income: 2016-2024

Historic Other Non Operating Income for Organogenesis Holdings (ORGO) over the last 9 years, with Dec 2024 value amounting to $20,000.

  • Organogenesis Holdings' Other Non Operating Income fell 65.38% to $18,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $66,000, marking a year-over-year increase of 200.00%. This contributed to the annual value of $20,000 for FY2024, which is 64.91% down from last year.
  • According to the latest figures from FY2024, Organogenesis Holdings' Other Non Operating Income is $20,000, which was down 64.91% from $57,000 recorded in FY2023.
  • In the past 5 years, Organogenesis Holdings' Other Non Operating Income ranged from a high of $97,000 in FY2020 and a low of -$1.9 million during FY2021.
  • Moreover, its 3-year median value for Other Non Operating Income was $20,000 (2024), whereas its average is $21,333.
  • As far as peak fluctuations go, Organogenesis Holdings' Other Non Operating Income slumped by 2,041.24% in 2021, and later soared by 538.46% in 2023.
  • Over the past 5 years, Organogenesis Holdings' Other Non Operating Income (Yearly) stood at $97,000 in 2020, then crashed by 2,041.24% to -$1.9 million in 2021, then skyrocketed by 99.31% to -$13,000 in 2022, then skyrocketed by 538.46% to $57,000 in 2023, then crashed by 64.91% to $20,000 in 2024.